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Abstract
Introduction: Pulmonary embolism is a challenging critical car-
diovascular disease with high morbidity and mortality. Surgi-
cal embolectomy has favorable results in patients with mas-
sive pulmonary embolism. 
Aim: To study the outcome of embolectomy in patients with 
massive pulmonary embolism. 
Material and methods: In this single-center, retrospective 
study, 36 patients including 14 male and 22 female patients 
with a mean age of 50.80 ±18.89 years with acute pulmonary 
embolism who underwent surgical pulmonary embolectomy 
from January 2011 to January 2016 were included. The medi-
cal records of all patients were reviewed for demographic and 
preoperative data and postoperative outcomes. 
Results: Common risk factors for acute PE were major surgery 
within 3 months and deep vein thrombosis. The most common 
presenting symptoms of patients were dyspnea, followed by 
chest pain and syncope. Mean duration of hospitalization was 
14.76 ±8.69 days and mean operation duration was 4.47 ±1.54 h. 
Mean time from admission to embolectomy was 6.58 ±1.13 h. 
Ten (27.8%) patients died during the operation including 
3 cases with cardiopulmonary resuscitation prior to surgery 
and 2 cases with severe cardiogenic shock. Patients who sur-
vived were followed for 6 months. The mortality rate during 
follow-up was 15.4%; all 4 patients died during follow-up pe-
riod due to metastatic cancer. No pulmonary embolism recur-
rance were seen.
Conclusions: Although surgical embolectomy mostly was done 
for high risk patients, it had good in-hospital and excellent 
mid-term outcomes. 
Key words: pulmonary embolism, surgical embolectomy, treat-
ment outcome, mortality, success rate.
Streszczenie
Wstęp: Zatorowość płucna jest bardzo niebezpieczną i trudną 
w leczeniu chorobą układu krążenia o wysokich wskaźnikach 
chorobowości i śmiertelności. Chirurgiczna embolektomia wią-
że się z korzystnymi wynikami u pacjentów z masywnymi za-
torami płucnymi. 
Cel: Zbadanie wyników embolektomii u tego typu pacjentów.
Materiał i metody: W jednoośrodkowym, retrospektywnym 
badaniu uczestniczyło 36 pacjentów (14 mężczyzn i 22 kobie-
ty, wiek średnio 50,80 ±18,89 roku) z ostrą zatorowością płuc-
ną, którzy przeszli zabiegi chirurgicznej embolektomii płucnej 
między styczniem 2011 a styczniem 2016 r. Dokumentację me-
dyczną pacjentów przeanalizowano pod kątem danych demo-
graficznych i przedoperacyjnych oraz wyników pooperacyjnych.
Wyniki: Częstymi czynnikami ryzyka wystąpienia ostrego za-
toru płucnego były poważna operacja chirurgiczna w ciągu 
3 miesięcy oraz zakrzepica żył głębokich. Wstępnymi objawami 
najczęściej zgłaszanymi przez pacjentów były kolejno: duszno-
ści, bóle klatki piersiowej i omdlenia. Średni czas hospitalizacji 
wyniósł 14,76 ±8,69 dnia, a średni czas zabiegu 4,47 ±1,54 go-
dziny. Średni czas od przyjęcia pacjenta do embolektomii wy-
niósł 6,58 ±1,13 godziny. Dziesięciu (27,8%) pacjentów zmarło 
w trakcie zabiegu; u 3 z nich wykonano przed zabiegiem re-
suscytację krążeniowo-oddechową, a u 2 doszło do ciężkiego 
wstrząsu kardiogennego. Pacjentów, którzy przeżyli, obserwo-
wano przez 6 miesięcy. Odsetek śmiertelności w czasie obser-
wacji wyniósł 15,4%; wszyscy 4 pacjenci zmarli w trakcie ob-
serwacji z powodu przerzutowego raka. Nie zaobserwowano 
przypadków nawrotów zatorowości płucnej.
Wnioski: Mimo że chirurgiczną embolektomię wykonywano 
głównie u pacjentów z wysokim ryzykiem, zastosowana meto-
da wiązała się z dobrymi wynikami wewnątrzszpitalnymi oraz 
doskonałymi wynikami średnioterminowymi.
Słowa kluczowe: zator płucny, embolektomia chirurgiczna, 
wynik leczenia, śmiertelność, wskaźnik skuteczności terapii.
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Introduction
Despite advances in diagnostics and therapeutics, pulmo-
nary embolism (PE) is one of the most critical cardiovascular 
diseases and is associated with high morbidity and mortality 
[1–4]. Massive PE is a life-threatening condition with a mor-
tality rate of 31–70% [5, 6]. Rapid intervention is necessary to 
restore pulmonary blood flow and stabilize the hemodynamic 
state. Pulmonary embolism is usually treated medically with 
anticoagulation; thrombolysis and surgical embolectomy are 
other treatments reserved for patients with massive PE and 
hemodynamically unstable patients [7, 8].
Today surgical embolectomy is a therapeutic option 
for patients who present with cardiogenic shock, have 
contraindications to thrombolysis or who have persistent 
hypotension after initial therapy [9, 10]. Previously, some 
researchers have reported that surgical embolectomy had 
a high mortality rate ranging from 16% to 64% [4]. By 
improvement in surgical techniques and experience of 
surgeons, recent studies have shown favorable results in 
massive PE with preserved hemodynamics with evidence 
of moderate to severe right ventricle (RV) dysfunction on 
echocardiography [11–17]. 
Aim
We conducted a retrospective single-center study of pa-
tients who underwent surgical embolectomy to investigate 
the efficacy of this treatment in PE patients.
Material and methods 
In this single-center, retrospective study, 36 patients 
over 18 years old with a definite diagnosis of acute PE who 
underwent surgical pulmonary embolectomy from January 
2011 to January 2016 were included. The study protocol was 
approved by the Tabriz University of Medical Sciences insti-
tutional review boards. 
Patients’ clinical records were reviewed and demo-
graphic information, initial presentation and symptoms, 
risk factors, methods of diagnosis, localization of throm-
botic material, indication for operation, mortality, and mor-
bidity were recorded. Pulmonary embolism diagnosis was 
confirmed by 36-slice computed tomography (CT) angiog-
raphy in all patients. Patients with persistent O2 saturation 
≤ 90% and/ or systolic blood pressure (BP) ≤ 90 or a drop of 
> 40 mm Hg from baseline BP lasting for 15 min or requir-
ing inotropic support with concomitant massive PE findings 
in computed tomography (CT) angiography (new throm-
bus formation in the common pulmonary artery trunk or 
right or left main pulmonary artery) and RV enlargement 
received fibrinolytic therapy as the first  line management 
and surgical embolectomy was done when dyspnea, low 
systolic BP and/or O2 saturation ≤ 90% continued after 
fibrinolytic  therapy  (defined  as  fibrinolytic  therapy  fail-
ure)  or when  there was  a  contraindication  to  fibrinolytic 
therapy. We used  intravenous fibrinolytic  therapy and  in-
terventional angiography was not done for patients. Low 
molecular weight or unfractionated heparin was adminis-
tered to normotensive patients with O2 saturation > 90%. 
A loading dose of 250,000 U of streptokinase over 30 min 
following 100,000 U/h for 24 h was used for most patients 
when fibrinolytic  therapy was  indicated. Recently fibrino-
lytic therapy protocol in our center has been changed to 
15 mg reteplase in two separate stat doses with a 30-min-
ute interval, which has been used in 5 patients. 
Surgical technique
The surgery was performed within 72 h of the initial 
thrombolysis through median sternotomy. After cardiopul-
monary bypass a longitudinal incision was performed on the 
main pulmonary artery trunk, extending the incision into the 
left pulmonary artery, and additional arteriotomy of the right 
pulmonary artery was performed when indicated. Using for-
ceps, thrombus removal was started, continuing to extract 
thrombi inside segmental pulmonary arteries if necessary. 
In some patients and after inducing moderate hypothermia, 
extracorporeal circulation was stopped for up to 30 min for 
better thrombus visualization and its complete extraction.
Post-intervention treatment
All patients received IV unfractionated heparin immedi-
ately after surgery or 2–4 h after streptokinase when the ac-
tivated partial thromboplastin time (aPTT) reached < 80 ms, 
or 15 min after recombinant tissue plasminogen activator 
(rTPA) therapy with a therapeutic aPTT ratio of two to three 
times the control value. Results are expressed as mean 
± SD or percentage.
Results
Thirty-six patients including 14 (38.9%) male and 22 (61.1%) 
female patients with a mean age of 50.80 ±18.89 years were 
evaluated. Mean time from admission to embolectomy was 
6.58 ±1.13 h. Risk factors for development of PE are presented 
in Table I. Common risk factors were major surgery within 
3 months and deep vein thrombosis. The most common pre-
senting symptoms of patients were dyspnea, followed by 
chest pain and syncope (Tab. II). 
Tab. I. Risk factors for pulmonary embolism
Condition Number (%)
Major surgery within 3 months 15 (41.7)
Deep vein thrombosis 14 (38.9)
Malignancy 4 (11.1)
Bedridden status 3 (8.3)
Tab. II. Presenting symptoms of patients
Condition Number (%)
Dyspnea 26 (72.2)
Syncope 2 (5.6)
Chest pain 2 (5.6)
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Mean CPKMB, CPK and CTnI were 30.47 ±19.75, 93.58 
±26.82 and 0.45 ±0.16, respectively. Mean systolic and diasto- 
lic blood pressure were 95.37 ±16.71 and 59.37 ±11.41 mm Hg, 
respectively. Mean heart rate was 103.35 ±17.63 bpm. 
ECG  findings  included  T invert in V1–V3 (15 cases, 
41.7%) and S1Q3T3 pattern (16 cases, 44.4%). Echocardiog-
raphy findings showed RV enlargement in 29 (80.6%) cases 
and RV dysfunction in 25 (69.4%). Mean RV size was 4.33 
±0.95. Mean left ventricular ejection fraction (LVEF) was 
50.75 ±6.01%. 
Mean duration of hospitalization was 14.76 ±8.69 days 
and mean operation duration was 4.47 ±1.54 h. Indications 
for surgical embolectomy are summarized in Table III.
Ten (27.8%) patients died during the operation including 
3 cases with cardiopulmonary resuscitation (CPR) prior to 
surgery and 2 cases with severe cardiogenic shock. One pa-
tient with active bleeding and one with transit clot in the RV 
developed severe cardiogenic shock before surgery and the 
operation was done for them before hemodynamic stability. 
The mortality rate of surgical embolectomy was 27.7%. After 
excluding the 5 above-mentioned cases, the mortality rate 
was 16.1%. Long duration of CPR and cardiogenic shock and 
their induced ischemic state can result in irreversible cardiac 
damage and death regardless of successful or unsuccessful 
embolectomy. We excluded these patients to determine the 
exact surgical embolectomy mortality. Causes of death were 
right ventricle failure in all cases except 1 patient with post-
operative acute renal failure and preoperative distal emboli 
resulting in lower extremity gangrene.
Patients who survived were followed for 6 months. The 
mortality rate during follow-up was 15.4%; all 4 patients 
died due to metastatic cancer. No recurrent PE was detected. 
Discussion
Pulmonary embolism is a challenging medical condition 
with significant morbidity and mortality. Massive PE is life 
threatening and requires aggressive management. Throm-
bolysis is the treatment of choice for massive PE [17]. Today 
surgical embolectomy is the second choice of treatment, 
and due to its acceptable outcomes its use is increasing for 
the management of massive and sometimes sub-massive 
PE [18, 19]. 
We evaluated 36 cases with massive PE undergoing 
primary or rescue surgical embolectomy. Mortality in our 
study was 27.7%, and after excluding patients under CPR or 
those with a prolonged state of shock mortality decreased 
to 16.1%, which are similar to most previous studies. Recent 
studies have indicated lower mortality and morbidity rates 
for surgical embolectomy with a mortality rate between 
3.6% and 29% [17–19]. While in stable patients mortality 
is  very  low,  in unstable patients  the situation  is different. 
Neely et al. reported the largest case series of surgical em-
bolectomy of 115 patients with submassive and massive PE 
with a mortality rate of 6.6% for all and 10.2% for massive 
PE [17]. Alizadeh et al. studied 12 massive PE patients and re-
ported a mortality rate of 16.6%. One of their patients died 
during the surgery and one in the intensive care unit [11]. 
It is reported that the mortality rate increases if CPR 
is required. Patients with massive PE, who presented with 
cardiac arrest and required CPR, had a mortality of up to 
70% within the first hour of presentation [14, 20]. A mortal-
ity rate of 57% for patients who required CPR was reported 
by Dauphine and Omari [20], while Yavuz et al. [14] reported 
a higher mortality rate of 75% for patients with CPR. 
Janata et al. reported a mortality rate of 85–95% in pa-
tients with cardiac arrest [21]. Leitner et al. reported that 
the cause of this high mortality could be coagulopathy sim-
ilar to disseminated intravascular coagulation (DIC) [22].
Hence, the underlying cause of PE should be evaluated 
in these patients. In our study, ten patients died during the 
surgery; three of them had CPR prior to surgery. In fact, 
the mortality rate for patients requiring CPR before surgery 
was 100%. Previous reports have noted that preoperative 
cardiogenic shock is an important predictor of survival af-
ter massive PE [8]. In our study also 2 patients with pro-
longed cardiogenic shock died because of RV failure.
It seems that because of many confounding factors 
such as duration of CPR, the experience of the CPR team, 
the time between cardiac arrest and operation [8], the dis-
tance of the operating room from the emergency room, and 
multi-organ damage induced by a state of shock, reporting 
the exact mortality for surgical embolectomy in very un-
stable patients is not easy.
Using RV support after embolectomy with delay ster-
nal closure may be helpful in patients with post-operative 
RV failure – a technique not available in some centers [23]. 
Most of the patients in our study died because of post-
operative RV failure. Right ventricle failure was the main 
cause of surgical embolectomy failure and mortality in our 
study. Continuous RV failure despite adequate embolecto-
my can be explained by several factors. In healthy people, 
the RV cannot continue contraction against a mean pres-
sure > 40 mm Hg [24]. In some cases a large burden of clot 
in small distal arteries, not suitable for embolectomy, es-
pecially when it affects both lungs, can still prevent RV af-
terload reduction despite adequate proximal embolectomy.
Right ventricle ischemia seems to be the second most 
important factor. By increasing RV end diastolic pressure 
the RV blood supply is decreased. Possible coronary artery 
obstruction  and  hypotension  aggravate  the  insufficient 
Tab. III. Indications for surgical embolectomy
Indications for surgical 
embolectomy
Total patients with 
embolectomy
36 (100%)
Patients died 
during or after 
surgery
10 (100%)
Recent surgery 15 (41.7%) 2 (20%)
Transit clot in RV or RA 12 (33.3%) 3 (30%)
Failure of thrombolysis 4 (11.1%) 1 (10%)
Active bleeding 2 (5.6%) 1 (10%)
Post CPR 3 (8.3%) 3 (30%)
RV – right ventricle, RA – right atrium
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blood supply [25]. The key point in this setting is the time. 
If surgical embolectomy is done when irreversible RV isch-
emic damage happens, the mortality will be high. Also in-
farct size is important. La Vecchia et al. found that ctnI was 
the strongest independent predictor of death in massive 
PE [26]. Hence, we need more investigations to define the 
golden time for surgical embolectomy in those with a state 
of shock and cardiac arrest undergoing CPR.
We observed a success rate of 84.6% during 6-month 
follow-up. Similar to our findings, Leacche et al. [4] reported 
3-year survival of 83% in 47 patients; and Fukuda et al. [27] 
also reported 10-year survival of 84% in 19 patients.
Prompt removal of emboli can save the life of a patient 
with acute massive PE. So, rapid evaluation of patients with 
massive PE, especially before cardiac arrest starts, would 
possibly increase the success rate. 
This study has several limitations. This was a retrospec-
tive nonrandomized study and all data were collected from 
medical records, so in some cases laboratory findings were 
not available. The study included a small sample size of 
massive PE and no submassive cases, which limits its gen-
eralizability. As an observational study, there were no other 
nonsurgical groups for comparison. 
Conclusions
Although surgical embolectomy is performed mostly 
for high-risk patients, it has good in-hospital and excellent 
mid-term outcomes. 
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